Celldex Therapeutics buy Cantor Fitzgerald
Start price
16.08.23
/
50%
€27.80
Target price
16.08.24
€49.46
Performance (%)
38.13%
Price
08.05.24
€38.40
Summary
This prediction is currently active. With a performance of 38.13% the BUY prediction by Cantor_Fitzgerald is a big success. This prediction currently runs until 16.08.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Celldex Therapeutics | 0.524% | 0.524% |
iShares Core DAX® | 4.094% | 3.543% |
iShares Nasdaq 100 | 1.424% | 0.512% |
iShares Nikkei 225® | -1.572% | -4.633% |
iShares S&P 500 | 1.822% | 0.963% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $54.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€38.80
22.03.24
22.03.24
€61.99
22.03.25
22.03.25
-1.03%
08.05.24
08.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€23.80
03.11.23
03.11.23
€48.43
03.11.24
03.11.24
61.34%
08.05.24
08.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.00
12.10.23
12.10.23
€51.15
12.10.24
12.10.24
51.20%
08.05.24
08.05.24
Celldex Therapeutics
Start price
Target price
Perf. (%)
€25.80
27.09.23
27.09.23
€51.25
27.09.24
27.09.24
46.51%
08.05.24
08.05.24